David V. Elkins serves as the Executive Vice President and Chief Financial Officer at Bristol Myers Squibb, a leading global biopharmaceutical company. In his role, Elkins is responsible for overseeing the company's financial operations, strategic planning, and investor relations. He plays a pivotal role in driving the company's growth and ensuring its financial stability as it continues to develop innovative medicines for patients worldwide. Elkins brings a wealth of experience to Bristol Myers Squibb, having held senior leadership positions in the financial sector for over two decades. Prior to joining the company, he served as the Executive Vice President and CFO at Allergan, where he was instrumental in driving the company's financial performance and strategic initiatives. Elkins has also held key positions at companies such as KPMG and Arthur Andersen, where he honed his expertise in financial management, mergers and acquisitions, and corporate governance. Under Elkins' leadership, Bristol Myers Squibb has continued to strengthen its financial position and invest in research and development to bring new treatments to market. His strategic vision and financial acumen have been crucial in navigating the complex landscape of the biopharmaceutical industry. Elkins' dedication to the company's mission of discovering, developing, and delivering innovative medicines has made him an invaluable asset to Bristol Myers Squibb and its stakeholders.